Pfizer Starts Testing For Over-The-Counter Lipitor

Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in the Wall Street Journal that the company has started a clinical study to support the application for low-dose atorvastatin (10 mg). … Click here to read the full post on Forbes.  
Source: CardioBrief - Category: Cardiology Authors: Tags: Policy & Ethics Prevention, Epidemiology & Outcomes atorvastatin cholesterol Lipitor over-the-counter statins Source Type: blogs